A novel system for the packaging of drugs as well as vaccines is presented.
Bacterial ghosts are intact, non-denatured bacterial envelopes that are cr
eated by lysis of bacteria through the: expression of cloned phage PhiX174
gene E. Inhibition of induced E-mediated lysis by MgSO4, harvesting of cell
s by centrifugation, and resuspension in low-ionic-strength buffers leads t
o rapid, violent lysis and results in empty bacterial envelopes with large
(approximately 1 mu m in diameter) openings. The construction of plasmid pA
V1, which encodes a streptavidin fusion protein with an N-terminal membrane
anchor sequence, allows the loading of the inner side of the cytoplasmic m
embrane with streptavidin. The functionality and efficacy of binding of eve
n large biotinylated compounds in such streptavidin ghosts (SA-ghosts) was
assessed using the enzyme alkaline phosphatase. The successful binding of b
iotinylated fluorescent dextran, as well as fluorescent DNA complexed with
biotinylated polylysine, was demonstrated microscopically. The display by b
acterial ghosts of morphological and antigenic surface structures of their
living counterparts permits their attachment to target tissues such as the
mucosal surfaces of the gastrointestinal and respiratory tract, and their u
ptake by phagocytes and M cells. In consequence, SA-ghosts are proposed as
drug carriers for site-specific drug delivery. (C) 1999 Elsevier Science B.
V. All rights reserved.